clindamycin

Approach to Treating Hidradenitis Suppurativa in Patients with Skin of Color: Insights from Dr. Ginette A. Okoye
Hidradenitis Suppurativa (HS) is a challenging dermatological condition characterized by painful, recurrent, and often disfiguring skin lesions. In this article, we will explore the expert insights of Dr. Ginette Okoye, Professor and Chair of the Howard University Department of Dermatology, as she discussed her approach to and experience with treating patients with HS at the 2023 Skin of Color Upd …
Mohs surgery – Friday Pop Quiz 9/16/2022
This patient calls the night before his Mohs surgery and is wondering whether he needs any antibiotics before his procedure tomorrow because he had knee replacements 3 months ago. Which of the following is the appropriate response? A. Advise him that he does not need any antibiotics B. Prescribe Cephalexin 2 gm PO x 1 an hour pre procedure C. Prescribe Clindamycin 600 mg PO x 1 an hou …
JDD March 2021 Issue Highlights: From OTC Products for Acne to MMS for Genital Skin Cancer
JDD MARCH 2021 ISSUEThe March issue of the Journal of Drugs in Dermatology features an outstanding line-up of articles with topics ranging from OTC products for acne to Mohs Micrographic Surgery for genital skin cancer. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Advisors agreed that OTC products and skincare recommendations, in addition to the use of prescription medications, …
JDD MARCH 2021 ISSUE
Acne News with Dr. Adam Friedman
acneStraight from the desk of ODAC Medical Director, Dr. Adam Friedman, we share what’s popping in acne (spoiler alert: quite a lot!). According to Dr. Friedman, the innovation drought is over! Watch as he reviews all new topical and oral therapeutics (some of which are completely new active agents) and while at it, shares and debunks important information related to the management of acne vulgaris …
acne
Tumor Necrosis Factor (TNF) Inhibitors Therapeutic Cheat Sheet
TNF inhibitors for psoriasisWith the advent of biologics, patients with moderate-to-severe plaque psoriasis have experienced increased control of disease and improved quality of life. Tumor necrosis factor (TNF) inhibitors are some of the earliest biologics prescribed for psoriasis, psoriatic arthritis and, more recently, hidradenitis suppurativa. In this month’s installment of Therapeutic Cheat Sheets, we discuss TNF inhi …
TNF inhibitors for psoriasis